A Caltech Library Service

Codominant interference, antieffectors, and multitarget drugs

Varshavsky, Alexander (1998) Codominant interference, antieffectors, and multitarget drugs. Proceedings of the National Academy of Sciences of the United States of America, 95 (5). pp. 2094-2099. ISSN 0027-8424. PMCID PMC19261.

PDF - Published Version
See Usage Policy.


Use this Persistent URL to link to this item:


The insufficient selectivity of drugs is a bane of present-day therapies. This problem is significant for antibacterial drugs, difficult for antivirals, and utterly unsolved for anticancer drugs, which remain ineffective against major cancers, and in addition cause severe side effects. The problem may be solved if a therapeutic agent could have a multitarget, combinatorial selectivity, killing, or otherwise modifying, a cell if and only if it contains a predetermined set of molecular targets and larks another predetermined set of targets. An earlier design of multitarget drugs [Varshavsky, A. (1995) Proc. Natl. Acad. Sci. USA 92, 3663-3667] was confined to macromolecular reagents such as proteins, with the attendant difficulties of intracellular delivery and immunogenicity. I now propose a solution to the problem of drug selectivity that is applicable to small (less than or equal to 1 kDa) drugs. Two ideas, codominant interference and antieffectors, should allow a therapeutic regimen to possess combinatorial selectivity, in which the number of positively and negatively sensed macromolecular targets can be two, three, or more. The nature of the effector and interference moieties in a multitarget drug determines its use: selective killing of cancer cells or, for example, the inhibition of a neurotransmitter-inactivating enzyme in a specific subset of the enzyme-containing cells. The in vivo effects of such drugs would be analogous to the outcomes of the Boolean operations "and," "or," and combinations thereof. I discuss the logic and applications of the antieffector and interference/codominance concepts, and the attendant problem of pharmacokinetics.

Item Type:Article
Related URLs:
URLURL TypeDescription CentralArticle
Varshavsky, Alexander0000-0002-4011-258X
Additional Information:© 1998 by the National Academy of Sciences. Contributed by Alexander Varshavsky, December 19, 1997. I thank L. Peck, G. Turner, D. Anderson, A. Rich, S. Mayo, E. Berezutskaya, and A. Kashina for comments on the manuscript. Studies in my laboratory are supported by grants from the National Institutes of Health. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Funding AgencyGrant Number
Subject Keywords:pharmacology, cancer, codominance, selectivity, genes
Issue or Number:5
PubMed Central ID:PMC19261
Record Number:CaltechAUTHORS:VARpnas98
Persistent URL:
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:1223
Deposited By: Tony Diaz
Deposited On:05 Jan 2006
Last Modified:02 Oct 2019 22:41

Repository Staff Only: item control page